Serhat Sekmek - Publications

Pretreatment HALP Score and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Receiving First-Line Tyrosine Kinase Inhibitors: A Turkish Oncology Group Kidney Cancer Consortium (TKCC) Study.

Journal: Cancers

Published: June 11, 2026

Feasibility and Prognostic Value of an Ovarian NAR-like Score in Advanced Ovarian Cancer Treated with Neoadjuvant Chemotherapy and Interval Debulking Surgery.

Journal: Journal of clinical medicine

Published: June 11, 2026

Prognostic Significance of the CPS-EG Score in Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy.

Journal: Cancers

Published: June 09, 2026

Clinical Significance of Achieving No Evidence of Disease in HER2-Positive Metastatic Breast Cancer: A Multicenter Study by Turkish Oncology Group (TOG).

Journal: Cancers

Published: February 12, 2026

Prognostic value of the glucose-to-lymphocyte ratio in surgically treated endometrial cancer: a retrospective cohort study.

Journal: Future oncology (London, England)

Published: January 29, 2026

Prognostic ımpact of the modified Ryan tumor regression score in gastric and GEJ adenocarcinomas treated with neoadjuvant FLOT regimen.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: December 17, 2025

Survival advantage of bevacizumab rechallenge in recurrent ovarian cancer regardless of platinum sensitivity.

Journal: Anti-cancer drugs

Published: November 11, 2025

Real-world effectiveness of total neoadjuvant therapy in locally advanced rectal cancer: a multicenter retrospective study.

Journal: Discover oncology

Published: October 10, 2025

Low muscle mass predicts poor response to neoadjuvant chemotherapy in advanced ovarian cancer.

Journal: Journal of ovarian research

Published: September 29, 2025

The Combined ALBI-FIB-4 Score for Prognostic Stratification in Hepatocellular Carcinoma: A Single Center Retrospective Study.

Journal: Journal of hepatocellular carcinoma

Published: September 08, 2025

Clinicopathologic Disease Characteristics and Their Association with Adjuvant Chemotherapy Outcomes in Pulmonary Large-Cell Carcinoma Patients with or Without Neuroendocrine Features.

Journal: Diagnostics (Basel, Switzerland)

Published: September 02, 2025

Association of RAD51 expression with response to neoadjuvant treatment and prognosis in locally advanced gastric cancer.

Journal: Expert review of anticancer therapy

Published: August 30, 2025